Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 9:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 3,459 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Metabolic Effects Clear all

Conditions: Overweight and Obesity
Interventions: Juice Plus; Dietary Supplement
Lead sponsor: Griffin Hospital; Other
Eligibility: 18 Years to 75 Years · Male only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Derby, Connecticut

Conditions: Type 1 Diabetes Mellitus
Interventions: cinnamon; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 13 Years to 18 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Multiple Sclerosis, Low Bone Density
Interventions: Copaxone, Interferon-beta 1a, Interferon-beta 1b; Drug
Lead sponsor: Nancy Hammond, MD; Other
Eligibility: 18 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: Kansas City, Kansas

Conditions: Type 1 Diabetes
Interventions: canagliflozin, basal interruption without canagliflozin; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Type 1 Diabetes
Interventions: Acipimox, Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 25 Years to 59 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Obesity
Interventions: Whey Protein supplement, Soy Protein Supplement, Carbohydrate supplement; Dietary Supplement
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years to 30 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Lawrence, Kansas

Conditions: Dehydration
Interventions: Oral Rehydration Solution (ORS), Water; Other
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 18 Years to 40 Years
Enrollment: 9 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Postprandial Glycemic Response, Postprandial Hyperglycemia, Postprandial Insulin
Interventions: Stair Stepping, No exercise control; Behavioral
Lead sponsor: San Diego State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 35 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: San Diego, California

Conditions: Obesity
Interventions: EndoFLIP device (FDA Device Listing Number : D091203); Device
Lead sponsor: Crospon; Industry
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Hurst, Texas

Conditions: Secondary Hyperparathyroidism, Hypercalcemia
Interventions: Cinacalcet HCl; Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Aging, Diabetes Mellitus, Type 2, PreDiabetes, Overweight and Obesity
Interventions: Semaglutide Injectable Product, Lifestyle Counseling; Drug · Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 65 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Diabetes, Hypercholesterolaemia, Hypertension, Obesity Type 2 Diabetes Mellitus, Obesity & Overweight, Heart Failure, CAD - Coronary Artery Disease, Stroke Risk, Cardiac Arrythmias, Genetics Hypertension, Genetics, Pharmacogenomics, Pharmacogenomic Testing for Medication Management, Cancer Genetics
Interventions: Color Genomics Genetic Testing Panels; Genetic
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Overweight, Cardiovascular Diseases
Interventions: High carbohydrate and low glycemic index (GI) diet, Low carbohydrate and low GI diet, High carbohydrate and high GI diet, Low carbohydrate and high GI diet; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 30 Years and older
Enrollment: 189 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Baltimore, Maryland • Boston, Massachusetts

Conditions: Obesity, Overweight
Interventions: Orforglipron, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 27
States / cities: Birmingham, Alabama • Pelham, Alabama • Santa Ana, California + 21 more

Conditions: Hypovitaminosis D
Interventions: Vitamin D, Placebo; Dietary Supplement
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Sodium Excess, Racial Disparities, Blood Pressure, Cardiovascular Risk Factor
Interventions: Low Sodium Meal (140 mg sodium chloride), High Sodium Meal (2500 mg sodium chloride); Other
Lead sponsor: Indiana University; Other
Eligibility: 19 Years to 75 Years
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 2
States / cities: Auburn, Alabama • Bloomington, Indiana

Conditions: Diabetes Mellitus, Type 2
Interventions: Ultrasound Vagus Nerve Stimulation (DECIMA); Device
Lead sponsor: Aucta Technologies, Inc.; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Scottsdale, Arizona

Conditions: Coronary Artery Disease, Diabetes Mellitus Type 2
Interventions: Glucagon-Like-Peptide-1/Regadenoson/Perflutren Lipid Microsphere; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 40 Years to 60 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Type 2 Diabetes, Insulin Resistance
Interventions: Study 2 (48 hours of complete bed rest); Other
Lead sponsor: University of New Mexico; Other
Eligibility: 21 Years to 75 Years
Enrollment: 16 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Albuquerque, New Mexico

Conditions: Diabetes Mellitus, Type 2
Interventions: LY2189265, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 755 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 42
States / cities: Phoenix, Arizona • Anaheim, California • Greenbrae, California + 39 more

Conditions: Osteoporosis
Interventions: ibandronate, Placebo; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 14
States / cities: Upland, California • Boulder, Colorado • Lakewood, Colorado + 10 more

Conditions: In Need of a Pap Smear (Cervical Cancer Screening), In Need of a Blood Pressure Check (Hypertension Screening), In Need of a Cholesterol Test (Lipid Disorder Screening), In Need of a Fasting Plasma Glucose Test (Diabetes)
Interventions: Planning Prompt, Control Condition; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 8,711 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Weight Loss
Interventions: Rimonabant (SR141716); Drug
Lead sponsor: Sanofi; Industry
Eligibility: 18 Years and older
Enrollment: 3,045 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2004
U.S. locations: 47
States / cities: Birmingham, Alabama • Phoenix, Arizona • Concord, California + 42 more

Conditions: Hyperlipidemias
Interventions: Lapaquistat acetate and fenofibrate, Fenofibrate; Drug
Lead sponsor: Takeda; Industry
Eligibility: 18 Years and older
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 32
States / cities: Huntsville, Alabama • Sierra Vista, Arizona • Beverly Hills, California + 29 more

Search by objective public record fields.

Effects of Juice Plus+® Supplementation on Endothelial Function in Overweight Men

The Effect of Cinnamon on HbA1c Among Adolescents With Type I Diabetes

Comparison of Bone Effects With Copaxone and Interferon in Multiple Sclerosis

Effect of Canagliflozin in T1DM (Type 1 Diabetes Melitus) After Interruption of Continuous Subcutaneous Insulin Infusion

Effects of Acipimox on Insulin Action, Vascular Function, and Muscle Function in Type 1 Diabetes

Whey Protein, Resistance Training, and Changes in Body Composition

Oral Rehydration Solution and Dehydration Recovery

Short, Simple, Exercise to Improve Circadian Dependent Postprandial Glycemic Responses

LapBand Adjustment to Improve Early Weight Loss

Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients

Effect of GLP1 Receptor Agonists on Physical Function, Body Composition, and Markers of Aging in Older Adults

The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans

Effect of Amount and Type of Dietary Carbohydrates on Risk for Cardiovascular Heart Disease and Diabetes

A Study of Orforglipron for the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities (ATTAIN-MAINTAIN)

The Effect of Hypovitaminosis D and Vitamin D Supplementation on Fracture Nonunion Rates

Vascular Effects of Acute Sodium (VEAS) Study

Acute Study of Effect of Ultrasound Vagus Nerve Stimulation on Glycemia

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

The Effects of Two Days of Bedrest on Insulin Resistance in Type 2 Diabetics

A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 Diabetes

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

The Effect of a Coloring Prompt on Health Engagement

Obese Patients With or Without Comorbidities (RIO-North America)

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels